Beta amyloid takes on a simple role in the advancement of Alzheimer’s disease, stated Professor Christopher Rowe, business lead investigator for imaging in the AIBL research. It is important that we have the ability to identify subjects with beta amyloid accumulation in order that we’re able to study its effects on the brain, but its results on subjects without or very specifically moderate symptoms. GE Healthcare’s involvement in AIBL implies that we are able to lengthen the cohort that gets this kind of test. .. Australian CSIRO, GE Health care partner for investigational PET imaging agent GE Health care today announced a collaboration with Australian Commonwealth Scientific and Industrial Study Organisation involving its investigational PET imaging agent [18F flutemetamol].Of the hedge money followed by, the Lone Pine Fund held the most valuable position – close to $613.3 million, or 3 % of the firm’s total fiscal year ’13 portfolio – in the agri-business giant. On the heels of Lone Pine Capital is certainly Andreas Halvorson of Viking Global, with a position of $414.5 million, or 2.3 % of its FY ’13 portfolio allocated to Monsanto. Various other peers with similar optimism consist of Phill Gross and Robert Atchinson’s Adage Capital Management, John Griffin’s Blue Ridge Capital and Jason Capello’s Merchants’ Gate Capital, writes Frias. Since Monsanto Organization has experienced declining interest from the entirety of the hedge money we track, logic holds that there exists a go for few hedgies that made a decision to sell off their positions entirely by the end of the second quarter.